Who We Are
Metabolomic Technologies Inc. is a fast growing company specializing in the development of novel metabolomics-based diagnostics for the healthcare market.
Our lead product, PolypDx™ is the first and only urine-based screening test for the detection and prevention of colorectal cancer.
Meet our team here
Quote From Our CEO
What an incredible journey it has been for our team. With a clear vision and a focus on innovation, we have introduced novel diagnostic methods to meet the needs of patients and healthcare providers. Metabolomics is an incredible untapped science for early-detection and screening, and we are thrilled to be at the forefront of its application in healthcare.
- Dr. David Chang, CEO
Our Award-winning Flagship Product
Our flagship product, PolypDx™, is the first and only urine-based test with a high sensitivity for detecting adenomatous polyps, the precursor to colorectal cancer. PolypDx™ provides healthcare professionals with a tool for early screening and detection, enabling the timely removal of polyps before they progress to colorectal cancer, thereby preventing cancer in the first place.
View our accolades
Teamwork Makes the Dream Work
We wouldn't be where we are today without our partners. Our partnerships validate our unique technology platform and its potential to provide innovative diagnostics for patients in need.
Browse through some of the incredible Partners we work with.